AI Can Help Determine A Person's Specific Form Of Dementia
By Dennis Thompson HealthDay Reporter
Medically reviewed by Drugs.com

TUESDAY, July 1, 2025 — A new AI tool can help doctors hone in on a patient’s particular type of dementia, including Alzheimer’s disease, a new study says.
The AI tool, StateViewer, helped researchers identify a person’s dementia type in 88% of cases, according to results newly published in the journal Neurology.
The tool could help doctors identify dementia early and precisely, even when patients had many medical conditions that could be contributing to their cognitive problems, researchers said.
"Every patient who walks into my clinic carries a unique story shaped by the brain's complexity," senior researcher Dr. David Jones, director of the Mayo Clinic Neurology Artificial Intelligence Program, said in a news release. “That complexity drew me to neurology and continues to drive my commitment to clearer answers.”
StateViewer reflects that commitment, he said, describing it as “a step toward earlier understanding, more precise treatment and, one day, changing the course of these diseases.”
Researchers trained and tested the AI on more than 3,600 brain imaging exams called fluorodeoxyglucose positron emission tomography (FDG-PET) scans, which show how the brain uses glucose for energy.
The AI compares a person’s brain images against a large database of scans from people with confirmed dementia diagnoses. It then identifies brain patterns that match specific types or combinations of dementia.
For example, Alzheimer’s typically affects memory and processing regions, researchers said.
On the other hand, Lewy body dementia involves areas associated with attention and movement, and frontotemporal dementia alters regions responsible for language and behavior.
Overall, the AI can sort through brain patterns associated with nine different types of dementia, researchers said.
Color-coded brain maps highlight key areas of brain activity, giving doctors a visual explanation of what the AI sees and why it has given a particular diagnosis.
"As we were designing StateViewer, we never lost sight of the fact that behind every data point and brain scan was a person facing a difficult diagnosis and urgent questions," lead researcher Leland Barnard, a data scientist with the Mayo Clinic, said in a news release.
"Seeing how this tool could assist physicians with real-time, precise insights and guidance highlights the potential of machine learning for clinical medicine,” he added.
Mayo Clinic researchers plan to expand the tool’s use and test its performance in a variety of clinical settings.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-02 00:00
Read more

- Digital Tool Potentially Predicts Childhood Asthma
- Senate Grills CDC Nominee Susan Monarez on Agency Cuts
- Incidence Rates of Appendiceal Adenocarcinoma Increasing
- Electronic Nudge Letters Do Not Improve Guideline-Directed Medical Therapy in CKD
- Disparities Seen in Continuous Glucose Monitor Rx by Language Preference
- Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions